Skip to main content

Table 2 Clinical profile of study population (n = 81)

From: Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease

Clinical featureN (%)
Motor symptoms
 Mobility
  Walking without support68 (84%)
  Walking with support6 (7.4%)
  Bedridden7 (8.6%)
 Falls (among those who can walk)
  No falls46 (56.8%)
  Infrequent falls (< 3/week)15 (18.5%)
  Frequent falls (≥3/week)13 (16%)
 Dysarthria56 (69%)
 Dysphagia28 (34.6%)
Behavioral/Psychiatric symptom
 Anger outbursts53 (65.4%)
 Low mood/Depressive symptoms43 (53%)
 Generalized anxiety39 (48.1%)
 Apathy27 (33.3%)
 Delusions (suspiciousness/fear of harm)32 (39.5%)
 Hallucinatory behavior (self-muttering/laughing)17 (20.9%)
 Obsessive-compulsive symptoms (repetitive behavior)17 (20.9%)
 Verbal perseverance27 (33.3%)
 Addictive behaviour18 (22.2%)
 Suicidal tendencies
  Attempted14 (17.2%)
  Ideation only4 (4.9%)
  Family history of suicide9 (11.1%)
Cognitive symptoms37 (45.6%)
Other Symptoms
 Sleep disturbances37 (45.6%)
 Ongoing weight loss40 (49.3%)
 Reduced appetite19 (23.4%)
 Increased appetite2 (2.5%)
 Bladder incontinence19 (23.4%)
 Bowel incontinence9 (11.1%)
 Constipation15 (18.5%)
 Diabetes mellitus9/74 (tested)
 Hypothyroidism12/68 (tested)